Global Vascular Grafts Market By Indication (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, Abdominal Aortic Aneurysms Repair and Thoracic Aortic Aneurysm Repair, and Peripheral Vascular Graft), By Raw Material (Polytetrafluoroethylene (PTFE), Polyester, Polyurethane, Biosynthetic, and Raw Material), By Application (Vascular Occlusion, Renal Failure, Coronary Artery Disease, and Cardiac Aneurysm), By End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The Global Vascular Grafts Market size is expected to be worth around USD 5.7 Billion by 2032 from USD 3.1 Billion in 2022, growing at a CAGR of 6.40% during the forecast period from 2023 to 2032.

A vascular graft is a surgical method that conveys the bloodstream from one part of the body to an alternative by recombining the blood vessels. Vascular grafting is usually prepared to bypass a complete or incomplete blockage in an artery in order to develop the flow of blood to the organ excluded by the blockage in the artery. A vascular graft is performed when there is an inadequate blood supply to the body caused by organ transplantation, hemodialysis, and atherosclerosis.

The main cause of vascular graft is cardiovascular disease, particularly peripheral artery disease, cerebrovascular disease, and coronary heart disease. A vascular graft is a process to surgically treat the injured or blockage in blood vessels to restore the blood flow by substituting the blood vessels.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• The Global Vascular Grafts Market is growing with a CAGR of 6.40%.
• Vascular grafts are surgical procedures used to reroute blood flow in cases of blockages, often caused by cardiovascular diseases.
• Rising awareness of vascular graft benefits and the prevalence of heart diseases are driving market growth.
• Product failures and recalls, strict regulations and high costs can hinder market expansion.
• Developing markets, especially in Japan, offer significant growth opportunities due to the aging population.
• The endovascular aneurysm repair stent graft segment accounted for 63.8% of market revenue in 2022.
• Polytetrafluoroethylene (PTFE) is the dominant raw material in vascular grafts due to its advantages.
• The cardiac aneurysm application held a major market share of 52% in 2022.
• Hospitals are the leading end-users in the market, while ambulatory surgical centers are expected to grow significantly.
• North America leads the market with a 35% revenue share, followed by the Asia-Pacific region due to the burden of cardiovascular diseases.
• Major players in the market include Medtronic plc, W. L Gore and Associates, Inc., C. R Bard, Inc., and others.

Driving Factors

Rising Awareness About the Benefits of Vascular Graft Anticipated to Support Market Revenue Growth

Increasing awareness about the profits of vascular grafts and increasing focus on early detection of disease conditions are other factors anticipated to continue to support market revenue growth over the forecast period. Stressful routines, unhealthy food habits, and alcohol abuse have been leading to the rising prevalence of various diseases, such as diabetes, which is a significant factor for numerous heart diseases. Bypass surgeries are done in patients suffering from a heart attack, angina pectoris, coronary artery diseases, atherosclerosis, and multiple heart artery blockages. The rising incidence of heart diseases is anticipated to support demand for vascular grafts and boost market growth going ahead.

In addition, the market expansion is being driven by an increase in the demand for minimally invasive procedures that aid in faster recovery as well as a rise in the number of surgical processes and research activities.

Additionally, the growth of the market is anticipated to be driven by new product launches, technological advancements, increasing laboratory computerization, and rising applications of screening in modified medicine.

Restraining Factors

Products Failures and Recalls

Product disappointments can have various or even lethal complications in patients above 65 years; numerous products existing by companies have been recalled from the market owing to product malfunctions or other issues. Market development can hurt the end user’s perception of the safety of grafts and affect their adoption in treatment procedures.

Strict government regulation regarding the manufacture and use of medical devices and increasing prices of grafts are the factors that can restrain the market growth during the forecast period. Additionally, big economic problem, a lack of qualified professionals, and probable complications related to bypass surgeries, such as bleeding and arrhythmias, is anticipated to hinder market growth to a certain extent.

Growth Opportunities

Developing Markets

Developing markets offer major growth opportunities for key players functioning in the vascular grafts market. As Japan has the largest amount of geriatric individuals, a rise in the population section will result in the rising occurrence of aortic aneurysms. Markets are anticipated to observe high growth in the upcoming years due to their relatively regulatory policies and the rising burden of aneurysms.

Indication Analysis

Endovascular Aneurysm Repair Segment to Witness Significant Growth During the Forecast Period

Based on indication, the global vascular grafts market is segmented into hemodialysis access graft, endovascular aneurysm repair stent graft, {abdominal aortic aneurysms repair, thoracic aortic aneurysm repair}, peripheral vascular graft, and bypass graft. The endovascular aneurysm repair stent graft section accounted for the largest market revenue share of 63.8% in 2022. The increasing adoption of endovascular aneurysm repair stent grafts, including thoracic aortic aneurysms, is the main factor contributing to the market growth. Moreover, these endovascular stents-grafts are specially used for the treatment of abdominal aortic aneurysms, thereby driving the market growth.

Additionally, these stent grafts can be utilized in conjunction with antibiotics to treat the mycotic aneurysm. In addition, it is projected that a rise in the demand for endovascular stent grafts will result in a shift from traditional open thoracic aorta surgeries to EVAR procedures. In addition, endovascular grafts are less painful than open heart surgeries and aid in quick recovery. Additionally, it reduces hospital stays, which increases its popularity.

Moreover, due to the rising incidence of renal failure and arterial hardening, the peripheral vascular grafts market is anticipated to expand at the fastest rate during the forecast period. In addition, over the course of the forecast period, it is anticipated that technological advancements in the development of products to treat peripheral artery disease will propel the segment’s growth.

By Raw Material Analysis

Polytetrafluoroethylene(PTFE) Segment Dominates the Market Growth

Based on raw material, the global vascular grafts market is divided into polytetrafluoroethylene {PTFE}, polyester, polyurethane, and biosynthetic. The Polytetrafluoroethylene segment held the highest market revenue. Due to its advantages, such as high potency rates and high-pressure tolerance Additionally, it is user-friendly and effectively interacts with the tissue. As a result, they are frequently used in extra-anatomical and peripheral bypass surgeries. In addition, it is expected that technological advancements like PTFE treated with argon plasma for the creation of novel products will accelerate the segment’s expansion.

Due to the availability of raw materials and benefits like durability and robustness, the polyester vascular graft market is anticipated to grow significantly. For instance, LeMaitre Polyester Vascular Graft and AbloGraft are joined and woven grafts that are made with cutting-edge sealant technology and enable the deep permeation of bovine skin collagen. Additionally, there has been a significant increase in the demand for efficient polyester vascular grafts with lesser widths as a result of the rising amount of patients with vascular heart disease.

By Application Analysis

Cardiac Aneurysm Segment Held the Largest Revenue Share of the Market

Based on application, the global vascular grafts market is divided into vascular occlusion, renal failure, coronary artery disease, and cardiac aneurysm. The cardiac aneurysm segment held a major market share of 52% in 2022. Due to the rise in the prevalence of high blood pressure, increase in cholesterol levels, and a rising geriatric population,

Additionally, developed tissue-engineered grafts used in hereditary heart surgeries are encouraging segment growth. Additionally, a rise in the use of invasive vascular implants has increased the need for cardiac aneurysm products due to the rising rates of organ transplant failure and surgical restoration for cardiovascular diseases.

The vascular occlusion segment is expected to enhance at the fastest rate over the forecast period. Due to the accessibility of graft-based processes and the rising amount of patients with vascular occlusion disease, Additionally, the use of synthetic grafts like polytetrafluoroethylene (PTFE) to treat vascular occlusion is anticipated to drive market expansion.

By End-User

Hospital Segment Anticipated to the Leading Segment in the Market

Based on End-User, the global vascular grafts market is classified into ambulatory surgical centers, specialty clinics, and hospitals. Among these, the hospital segment is anticipated to maintain its lead during the forecast period due to the reliability of polyester material. Moreover, ambulatory surgical centers are anticipated to witness considerable growth during the forecast period, owing to a rise in the numeral of ambulatory surgical centers.

Key Market Segments

By Indication

• Hemodialysis Access Graft
• Endovascular Aneurysm Repair Stent Graft
• Abdominal Aortic Aneurysms Repair
• Thoracic Aortic Aneurysm Repair
• Peripheral Vascular Graft

By Raw Material

• Polytetrafluoroethylene(PTFE)
• Polyester
• Polyurethane
• Biosynthetic

By Application

• Vascular Occlusion
• Renal Failure
• Coronary Artery Disease
• Cardiac Aneurysm

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Regional Analysis

North America Region Dominated the global Vascular Grafts Market  with Highest Market Revenue Share

North America accounted for a significant vascular grafts market revenue share of 35%. Due to the increase in the prevalence of chronic diseases, advanced healthcare facilities, adequate reimbursement strategies in the region, and availability of significant facilities for well-functioning cardiovascular problems have contributed to the development of the market.

Moreover, the Asia-Pacific region is expected to witness fast growth during the projection phase. The region is heavily burdened by the rising amount of patients with cardiovascular disease. Diabetes and end-stage heart diseases.

Key Regions and Countries

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America

• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Leading companies are adopting several strategies, such as acquisitions, mergers, collaborations, and new product development. Among others, to stay ahead of the competition and develop market revenue share. The prominent key players operating the global vascular market include B. Braun Melsungen AG, Medtronic plc, W. L Gore and Associates, Inc., C. R Bard, Inc., and others. These companies mainly focus on expanding customer reach and accelerating production capacity to drive their market position.

Key Market Players

The following are some of the major players in the global vascular grafts market industry

• Medtronic plc
• LeMaitre Vascular, Inc.
• Cook Group, Inc.
• L Gore and Associates, Inc.
• R Bard, Inc.
• Getinge AB
• Terumo Medical Corporation
• Shanghai Suokang Medical Implants Co, Ltd
• Braun Melsungen AG
• Becton, Dickinson, and Company
• Other Key Players

Recent Developments

• March 2021 – The Zenith fenestrated endovascular graft is a medical device that the FDA approved. Due to its effectiveness in treating and diagnosing debilitating conditions, this product is anticipated to generate significant sales revenue.
• October 2021- Terumo Aortic acknowledged adoption for the abdominal aortic stent grafts. This device will help in the cure of abdominal aortic aneurysms.
• June 2020- Artegraft, Inc. was developed by LeMaitre Vascular Inc. This achievement helped in gaining decline to the Artegraft Inc. portfolio of biological vascular grafts.

Report Scope